Denali Therapeutics Inc Investor Relations Material
Denali Therapeutics, Inc. is a biopharmaceutical company that discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. The company has been operating its business since 2013
Latest company events
Ticker symbol
DNLI
Country
United States of America
About the company
Investor Relations Page
Dig deeper into the Denali Therapeutics Inc fundamentals on Quartr.
- Skip straight to the Q&A session
- Receive notifications about new events
- Connect the financial calender on your phone
- Figure out why the stock is up or down
- Read the transcripts or scroll the deck
- Access earnings or press releases
